{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:12:56Z","timestamp":1790071976815,"version":"4.0.1"},"reference-count":58,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2022J011494"],"award-info":[{"award-number":["2022J011494"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Lipid metabolism participates in various physiological processes and has been shown to be connected to the development and progression of multiple diseases, especially metabolic hepatopathy. Apolipoproteins (Apos) act as vectors that combine with lipids, such as cholesterol and triglycerides (TGs). Despite being involved in lipid transportation and metabolism, the critical role of Apos in the maintenance of lipid metabolism has still not been fully revealed. This study sought to clarify variations related to m6A methylome in ApoF gene knockout mice with disordered lipid metabolism based on the bioinformatics method of transcriptome-wide m6A methylome epitranscriptomics. High-throughput methylated RNA immunoprecipitation sequencing (MeRIP-seq) was conducted in both wild-type (WT) and ApoF knockout (KO) mice. As a result, the liver histopathology presented vacuolization and steatosis, and the serum biochemical assays reported abnormal lipid content in KO mice. The m6A-modified mRNAs were conformed consensus sequenced in eukaryotes, and the distribution was enriched within the coding sequences and 3\u2032 non-coding regions. In KO mice, the functional annotation terms of the differentially expressed genes (DEGs) included cholesterol, steroid and lipid metabolism, and lipid storage. In the differentially m6A-methylated mRNAs, the functional annotation terms included cholesterol, TG, and long-chain fatty acid metabolic processes; lipid transport; and liver development. The overlapping DEGs and differential m6A-modified mRNAs were also enriched in terms of lipid metabolism disorder. In conclusion, transcriptome-wide MeRIP sequencing in ApoF KO mice demonstrated the role of this crucial apolipoprotein in liver health and lipid metabolism.<\/jats:p>","DOI":"10.3390\/genes15030347","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T06:05:30Z","timestamp":1710137130000},"page":"347","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unveiling the Impact of ApoF Deficiency on Liver and Lipid Metabolism: Insights from Transcriptome-Wide m6A Methylome Analysis in Mice"],"prefix":"10.3390","volume":"15","author":[{"given":"Xuebin","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Affiliated Nanping First Hospital, Fujian Medical University, Nanping 353000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5850-2578","authenticated-orcid":false,"given":"Mengting","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Nanping First Hospital, Fujian Medical University, Nanping 353000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Nanping First Hospital, Fujian Medical University, Nanping 353000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jionghong","family":"Tu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6025-8957","authenticated-orcid":false,"given":"Kunqi","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9821-2946","authenticated-orcid":false,"given":"An","family":"Zhu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanghua","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Affiliated Nanping First Hospital, Fujian Medical University, Nanping 353000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041433-199908000-00006","article-title":"Cholesteryl ester transfer protein and its plasma regulator: Lipid transfer inhibitor protein","volume":"10","author":"Morton","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/hq1001.096722","article-title":"Markedly elevated lipid transfer inhibitor protein in hypercholesterolemic subjects is mitigated by plasma triglyceride levels","volume":"21","author":"Morton","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/hep.32631","article-title":"Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism","volume":"77","author":"Deprince","year":"2023","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","article-title":"Plasma lipoproteins: Apolipoprotein structure and function","volume":"25","author":"Mahley","year":"1984","journal-title":"J. Lipid Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/CIRCULATIONAHA.105.593855","article-title":"Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport","volume":"113","author":"Duffy","year":"2006","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jama.298.7.786","article-title":"High-density lipoprotein as a therapeutic target: A systematic review","volume":"298","author":"Singh","year":"2007","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1194\/jlr.M300171-JLR200","article-title":"CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL","volume":"44","author":"Morton","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lagor, W.R., Fields, D.W., Khetarpal, S.A., Kumaravel, A., Lin, W., Weintraub, N., Wu, K., Hamm-Alvarez, S.F., Drazul-Schrader, D., and de la Llera-Moya, M. (2012). The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031616"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bbrc.2013.10.156","article-title":"Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice","volume":"441","author":"Li","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2015.02.013","article-title":"Transcriptional regulation of the apolipoprotein F (ApoF) gene by ETS and C\/EBP\u03b1 in hepatoma cells","volume":"112","author":"Shen","year":"2015","journal-title":"Biochimie"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1194\/jlr.M700258-JLR200","article-title":"Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects","volume":"49","author":"Morton","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1194\/jlr.P008268","article-title":"Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease","volume":"51","author":"Peloso","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1194\/jlr.M800429-JLR200","article-title":"Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia","volume":"50","author":"Izem","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.aau1646","article-title":"RNA modifications modulate gene expression during development","volume":"361","author":"Frye","year":"2018","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/imr.13020","article-title":"How RNA modifications regulate the antiviral response","volume":"304","author":"Thompson","year":"2021","journal-title":"Immunol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41416-023-02275-1","article-title":"RNA modifications in cancer","volume":"129","author":"Tang","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e105977","DOI":"10.15252\/embj.2020105977","article-title":"m6A RNA methylation: From mechanisms to therapeutic potential","volume":"40","author":"He","year":"2021","journal-title":"EMBO J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omto.2021.05.003","article-title":"Regulatory role and mechanism of m6A RNA modification in human metabolic diseases","volume":"22","author":"Zhang","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"866116","DOI":"10.3389\/fendo.2022.866116","article-title":"The role of RNA m6A methylation in lipid metabolism","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gendis.2021.01.005","article-title":"Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders","volume":"9","author":"Yang","year":"2021","journal-title":"Genes Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"146224","DOI":"10.1016\/j.gene.2022.146224","article-title":"FTO knockout in adipose tissue effectively alleviates hepatic steatosis partially via increasing the secretion of adipocyte-derived IL-6","volume":"818","author":"Zeng","year":"2022","journal-title":"Gene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13046-022-02254-z","article-title":"FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner","volume":"41","author":"Huang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.gpb.2020.06.003","article-title":"m6A Regulates Liver Metabolic Disorders and Hepatogenous Diabetes","volume":"18","author":"Li","year":"2020","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fong, A.S., Pan, Y., Yu, J., and Wong, C.C. (2022). Interplay between the m6A Epitranscriptome and Tumor Metabolism: Mechanisms and Therapeutic Implications. Biomedicines, 10.","DOI":"10.3390\/biomedicines10102589"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1166\/jnn.2017.12849","article-title":"Role of Oxidative Stress and Inflammatory Response in Subchronic Pulmonary Toxicity Induced by Nano Nickel Oxide in Rats","volume":"17","author":"Zhu","year":"2017","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/bioinformatics\/btt171","article-title":"Exome-based analysis for RNA epigenome sequencing data","volume":"29","author":"Meng","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Duan, D., Tang, W., Wang, R., Guo, Z., and Feng, H. (2023). Evaluation of epitranscriptome-wide N6-methyladenosine differential analysis methods. Brief Bioinform., 24.","DOI":"10.1093\/bib\/bbad139"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/bioinformatics\/btaa938","article-title":"MetaTX: Deciphering the distribution of mRNA-related features in the presence of isoform ambiguity, with applications in epitranscriptome analysis","volume":"37","author":"Wang","year":"2021","journal-title":"Bioinformatics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/bioinformatics\/btab203","article-title":"STREME: Accurate and versatile sequence motif discovery","volume":"37","author":"Bailey","year":"2021","journal-title":"Bioinformatics"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/nprot.2016.095","article-title":"Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown","volume":"11","author":"Pertea","year":"2016","journal-title":"Nat. Protoc."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/bioinformatics\/bts251","article-title":"DAVID-WS: A stateful web service to facilitate gene\/protein list analysis","volume":"28","author":"Jiao","year":"2012","journal-title":"Bioinformatics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"W317","DOI":"10.1093\/nar\/gkab447","article-title":"KOBAS-i: Intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis","volume":"49","author":"Bu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"D287","DOI":"10.1093\/nar\/gkab702","article-title":"POSTAR3: An updated platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins","volume":"50","author":"Zhao","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"16464","DOI":"10.3748\/wjg.v20.i44.16464","article-title":"Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development","volume":"20","author":"Jiang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.24376","article-title":"Endpoints and clinical trial design for nonalcoholic steatohepatitis","volume":"54","author":"Sanyal","year":"2011","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1039\/C8FO02379D","article-title":"Soybean soluble polysaccharides enhance bioavailability of genistein and its prevention against obesity and metabolic syndrome of mice with chronic high fat consumption","volume":"10","author":"Lu","year":"2019","journal-title":"Food Funct."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/ehu319","article-title":"Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin","volume":"36","author":"Kuhnast","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Schaefer, M.R. (2021). The Regulation of RNA Modification Systems: The Next Frontier in Epitranscriptomics?. Genes, 12.","DOI":"10.3390\/genes12030345"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.gpb.2017.03.003","article-title":"Epitranscriptomics: Toward A Better Understanding of RNA Modifications","volume":"15","author":"Xiong","year":"2017","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Song, H., Zhang, J., Liu, B., Xu, J., Cai, B., Yang, H., Straube, J., Yu, X., and Ma, T. (2022). Biological roles of RNA m5C modification and its implications in Cancer immunotherapy. Biomark. Res., 10.","DOI":"10.1186\/s40364-022-00362-8"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/toxsci\/kfab021","article-title":"Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology","volume":"181","author":"Malovic","year":"2021","journal-title":"Toxicol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wu, Y., Chen, X., Bao, W., Hong, X., Li, C., Lu, J., Zhang, D., and Zhu, A. (2022). Effect of Humantenine on mRNA m6A Modification and Expression in Human Colon Cancer Cell Line HCT116. Genes, 13.","DOI":"10.3390\/genes13050781"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e1460","DOI":"10.1002\/ctm2.1460","article-title":"Crosstalk between m6A modification and alternative splicing during cancer progression","volume":"13","author":"Zhu","year":"2023","journal-title":"Clin Transl Med"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"D106","DOI":"10.1093\/nar\/gkac1061","article-title":"DirectRMDB: A database of post-transcriptional RNA modifications unveiled from direct RNA sequencing technology","volume":"51","author":"Zhang","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jhep.2020.04.009","article-title":"Epitranscriptomics in liver disease: Basic concepts and therapeutic potential","volume":"73","author":"Zhao","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/oby.23932","article-title":"Update on N6-methyladenosine methylation in obesity-related diseases","volume":"32","author":"Cheng","year":"2024","journal-title":"Obesity"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Tang, Z., Sun, C., Yan, Y., Niu, Z., Li, Y., Xu, X., Zhang, J., Wu, Y., Li, Y., and Wang, L. (2023). Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs. J. Mol. Cell Biol., 14.","DOI":"10.1093\/jmcb\/mjac061"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12033-020-00269-5","article-title":"m6A RNA Methylation: Ramifications for Gene Expression and Human Health","volume":"62","author":"Karthiya","year":"2020","journal-title":"Mol. Biotechnol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41419-024-06520-0","article-title":"IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD","volume":"15","author":"Han","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e2304895","DOI":"10.1002\/advs.202304895","article-title":"m6A-Modified circTET2 Interacting with HNRNPC Regulates Fatty Acid Oxidation to Promote the Proliferation of Chronic Lymphocytic Leukemia","volume":"10","author":"Wu","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nchembio.2051","article-title":"AIG1 and ADTRP are atypical integral membrane hydrolases that degrade bioactive FAHFAs","volume":"12","author":"Parsons","year":"2016","journal-title":"Nat. Chem. Biol."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/3\/347\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:11:14Z","timestamp":1760105474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/3\/347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,9]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["genes15030347"],"URL":"https:\/\/doi.org\/10.3390\/genes15030347","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,9]]}}}